Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)

NCT07584083 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Antiphospholipid Syndrome (APS)

Interventions

DRUG: Anifrolumab

Sponsor

National and Kapodistrian University of Athens

Collaborators

[object Object]